MarketCapTrends
AIM
AIM ImmunoTech Inc. (AIM)
NYSE · Healthcare

AIM ImmunoTech Inc. Total Liabilities 2009–2025

AIM ImmunoTech Inc. annual/quarterly total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • AIM ImmunoTech Inc. total liabilities for the quarter ending December 31, 2025 were 15.6M, a 56.75% increase year-over-year.
  • AIM ImmunoTech Inc. total liabilities for 2025 were 15.6M, a 56.75% increase from 2024.
  • AIM ImmunoTech Inc. total liabilities for 2024 were 9.9M, a 8.56% increase from 2023.
  • AIM ImmunoTech Inc. total liabilities for 2023 were 9.1M, a 352.82% increase from 2022.
  • AIM ImmunoTech Inc. total liabilities for 2022 were 2.0M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
AIM ImmunoTech Inc. Annual Total Liabilities (Millions of US $)
2025$16
2024$10
2023$9
2022$2
2014$4
2013$3
2012$13
2011$6
2010$6
AIM ImmunoTech Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$16
2024-12-31$10
2023-12-31$9
2022-12-31$2
2014-12-31$4
2013-12-31$3
2012-12-31$13
2011-12-31$6
2010-12-31$6

AIM ImmunoTech Inc. Total Liabilities — FAQ

AIM ImmunoTech Inc. (AIM) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AIM's total liabilities history?

The chart and table above show AIM ImmunoTech Inc.'s total liabilities by year and by quarter, including the growth rate.